Karin Friis Bach

Medication history on internal medicine wards: assessment of extra information collected from second drug interviews and GP lists

Stig Ejdrup Andersen, A Pedersen, Karin Friis Bach · Pharmacoepidemiology and Drug Safety · 2003 · 56 citations

Medicine, Internal Medicine, Clinical Pharmacology +12

Effect of European Clinical Trials Directive on academic drug trials in Denmark: retrospective study of applications to the Danish Medicines Agency 1993-2006

Louise Berendt, Cecilia Håkansson, Karin Friis Bach et al. · BMJ · 2007 · 24 citations · Full text

Pharmacy, Pharmaceutical Policy, Clinical Research Regulation +10

A Paradigm Shift Towards Patient Involvement in Medicines Development and Regulatory Science: Workshop Proceedings and Commentary

Gitte Borup, Karin Friis Bach, Merete Schmiegelow et al. · Therapeutic Innovation & Regulatory Science · 2016 · 21 citations

Pharmacy, Pharmaceutical Policy, Drug Approval Processes +12

Barriers towards the publication of academic drug trials. Follow-up of trials approved by the Danish Medicines Agency

Louise Berendt, Lene Grejs Petersen, Karin Friis Bach et al. · PLoS ONE · 2017 · 19 citations · Full text

Medicine, Pharmacology, Clinical Pharmacology +8

From protocol to published report: a study of consistency in the reporting of academic drug trials

Louise Berendt, Torbjörn Callréus, Lene Grejs Petersen et al. · Trials · 2016 · 13 citations · Full text

Pharmacy, Pharmacology, Evidence-based Practice +15